1,646 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ICLR

ICON
US$312.51-2.7%49.8%US$26.3bUS$351.79PE42.1xE15.7%n/a

BNTX

BioNTech
US$88.65-2.3%-29.5%US$21.7bUS$115.95PE21.4xE-20.6%n/a

ILMN

Illumina
US$131.172.7%-42.2%US$21.3bUS$160.46PS4.6xE68.5%n/a

WAT

Waters
US$337.15-1.2%11.2%US$20.4bUS$325.13PE31.1xE6.5%n/a

ALNY

Alnylam Pharmaceuticals
US$152.411.0%-24.9%US$19.7bUS$220.22PS10.5xE60.6%n/a

RPRX

Royalty Pharma
US$29.452.3%-18.4%US$17.8bUS$45.62PE11.6xE5.9%2.9%

AVTR

Avantor
US$25.561.1%20.1%US$17.6bUS$27.75PE54.1xE27.2%n/a

BMRN

BioMarin Pharmaceutical
US$90.214.0%-7.9%US$16.9bUS$109.83PE102.1xE30.4%n/a

BGNE

BeiGene
US$149.76-1.4%-41.2%US$16.1bUS$268.64PS6.4xE56.2%n/a

TEVA

Teva Pharmaceutical Industries
US$13.85-1.9%48.0%US$15.7bUS$15.15PB2.1xE46.5%0%

VTRS

Viatris
US$11.71-2.6%19.2%US$14.0bUS$12.40PE254.2xE16.0%4.1%

NBIX

Neurocrine Biosciences
US$138.090.4%34.1%US$13.8bUS$152.09PE55xE26.6%n/a

RVTY

Revvity
US$107.905.4%-19.7%US$13.7bUS$123.11PE74.3xE24.1%0.3%

EXAS

Exact Sciences
US$73.601.1%13.4%US$13.5bUS$88.49PS5.3xE61.5%n/a

CRL

Charles River Laboratories International
US$247.49-4.6%22.8%US$13.2bUS$270.67PE26.8xE11.4%n/a

KRTX

Karuna Therapeutics
US$329.833.3%80.7%US$12.6bUS$326.92PS19238.9xE60.1%n/a

MEDP

Medpace Holdings
US$397.720.4%109.8%US$12.5bUS$402.04PE43.6xE14.7%n/a

INCY

Incyte
US$55.00-0.6%-25.6%US$12.4bUS$76.10PE20.7xE20.0%n/a

BRKR

Bruker
US$88.53-2.7%8.9%US$12.4bUS$85.20PE28.5xE2.5%0.2%

SRPT

Sarepta Therapeutics
US$126.31-0.5%-8.3%US$11.9bUS$164.59PS9.5xE42.3%n/a

NTRA

Natera
US$96.504.2%88.6%US$11.8bUS$98.61PS10.8xE68.0%n/a

TECH

Bio-Techne
US$69.512.4%-14.4%US$11.2bUS$80.68PE48.8xE10.4%0.5%

UTHR

United Therapeutics
US$237.792.9%5.3%US$11.2bUS$285.49PE11.4xE7.6%n/a

CTLT

Catalent
US$57.020.6%-11.3%US$10.3bUS$63.50PS2.5xE92.3%n/a
Page 2 of 69
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.